OTCPK:CRWR.Y

Stock Analysis Report

Executive Summary

Craneware plc, together with its subsidiaries, develops, licenses, and supports computer software for the healthcare industry in the United States.

Snowflake

Fundamentals

Flawless balance sheet with solid track record.


Similar Companies

Share Price & News

How has Craneware's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

0%

OTCPK:CRWR.Y

2.1%

US Healthcare Services

1.1%

US Market


1 Year Return

n/a

OTCPK:CRWR.Y

7.7%

US Healthcare Services

2.1%

US Market

No trading data on CRWR.Y.

No trading data on CRWR.Y.


Share holder returns

CRWR.YIndustryMarket
7 Day0%2.1%1.1%
30 Day-3.4%-4.7%3.7%
90 Dayn/a-4.6%2.3%
1 Yearn/a7.7%7.7%4.4%2.1%
3 Year249.5%234.9%51.1%50.8%47.0%37.4%
5 Yearn/a49.2%48.3%61.6%43.8%

Price Volatility Vs. Market

How volatile is Craneware's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is Craneware undervalued based on future cash flows and its price relative to the stock market?

53.24x

Price to Earnings (PE) ratio


Intrinsic Value Based on Future Cash Flows

Craneware's share price is above the future cash flow value, it's not available at a moderate discount (< 20%).

Craneware's share price is above the future cash flow value, it's not available at a substantial discount (< 40%).


Price Based on Earnings

Craneware is good value based on earnings compared to the US Healthcare Services industry average.

Craneware is overvalued based on earnings compared to the United States of America market.


Price Based on Expected Growth

Craneware is poor value based on expected growth next year.


Price Based on Value of Assets

Craneware is overvalued based on assets compared to the US Healthcare Services industry average.


Next Steps

Future Growth

How is Craneware expected to perform in the next 1 to 3 years based on estimates from 5 analysts?

15.3%

Forecasted annual earnings growth


Earnings and Revenue Growth Estimates


Future Annual Growth Analysis

Craneware's revenue is expected to grow by 16.4% yearly, however this is not considered high growth (20% yearly).

Craneware's earnings are expected to grow by 15.3% yearly, however this is not considered high growth (20% yearly).

Craneware's revenue growth is expected to exceed the United States of America market average.

Craneware's earnings growth is expected to exceed the United States of America market average.

Craneware's earnings growth is expected to exceed the low risk savings rate of 2.7%.


Earnings per Share Growth Estimates


Future Return on Equity

Craneware is expected to efficiently use shareholders’ funds in the future (Return on Equity greater than 20%).


Next Steps

Past Performance

How has Craneware performed over the past 5 years?

15.2%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Craneware's year on year earnings growth rate has been positive over the past 5 years.

Craneware's 1-year earnings growth exceeds its 5-year average (15.5% vs 15.2%)

Craneware's earnings growth has not exceeded the US Healthcare Services industry average in the past year (15.5% vs 23.6%).


Return on Equity

Craneware has efficiently used shareholders’ funds last year (Return on Equity greater than 20%).


Return on Assets

Craneware used its assets more efficiently than the US Healthcare Services industry average last year based on Return on Assets.


Return on Capital Employed

Craneware has significantly improved its use of capital last year versus 3 years ago (Return on Capital Employed).


Next Steps

Financial Health

How is Craneware's financial position?


Financial Position Analysis

Craneware is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.

Craneware has no long term commitments.


Debt to Equity History and Analysis

Craneware has no debt.

Craneware has not taken on any debt in the past 5 years.

Craneware has no debt, it does not need to be covered by operating cash flow.

Craneware has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet

Low level of unsold assets.

Craneware has no debt, it does not need to be covered by short term assets.


Next Steps

Dividend

What is Craneware's current dividend yield, its reliability and sustainability?

1.34%

Expected Dividend Yield


Dividend Yield and Payments Analysis

Craneware's pays a lower dividend yield than the bottom 25% of dividend payers in United States of America (1.4%).

Craneware's dividend is below the markets top 25% of dividend payers in United States of America (3.64%).

Dividends per share have been volatile in the past 10 years (annual drop of over 20%).

Dividends per share have fallen over the past 10 years.


Current Payout to Shareholders

Dividends paid are covered by earnings (1.9x coverage).


Future Payout to Shareholders

Dividends after 3 years are expected to be covered by earnings (1.7x coverage).


Next Steps

Management

What is the CEO of Craneware's salary, the management and board of directors tenure and is there insider trading?

10.6yrs

Average management tenure


CEO

Keith Neilson (49yo)

20.3yrs

Tenure

US$878,000

Compensation

Mr. Keith Neilson co-founded Craneware PLC in 1999 and has served as its Chief Executive Officer ever since. Keith’s direction has helped Craneware to win multiple prestigious awards in such areas as inter ...


CEO Compensation Analysis

Keith's remuneration is lower than average for companies of similar size in United States of America.

Keith's compensation has increased by more than 20% in the past year.


Management Age and Tenure

10.6yrs

Average Tenure

The average tenure for the Craneware management team is over 5 years, this suggests they are a seasoned and experienced team.


Board Age and Tenure

8.0yrs

Average Tenure

61.5yo

Average Age

The tenure for the Craneware board of directors is about average.


Insider Trading

No 3 month insider trading information.


Ownership Breakdown


Management Team

  • Craig Preston (47yo)

    CFO, Company Secretary & Executive Director

    • Tenure: 10.6yrs
    • Compensation: US$656.43k
  • Keith Neilson (49yo)

    Co-Founder

    • Tenure: 20.3yrs
    • Compensation: US$878.00k
  • Derek Paterson

    Chief Information Officer

    • Tenure: 18.6yrs
  • Issy Urquhart

    Chief People Officer

    • Tenure: 3.3yrs
  • Karen Bowden

    Executive Vice President of Customer Management

    • Tenure: 18.3yrs
  • Mark Montgomery

    Chief Marketing Officer

    • Tenure: 5.6yrs
  • Seth Droe

    Executive Vice President of Sales

    • Tenure: 5.9yrs
  • Marty Smith

    Chief Technology Officer

    • Tenure: 0yrs

Board Members

  • Ron Verni (70yo)

    Senior Independent Non-Executive Director

    • Tenure: 0yrs
    • Compensation: US$58.66k
  • George Elliott (65yo)

    Non-Executive Chairman

    • Tenure: 11.7yrs
    • Compensation: US$104.14k
  • Russ Rudish (65yo)

    Non-Executive Director

    • Tenure: 4.7yrs
    • Compensation: US$52.39k
  • Craig Preston (47yo)

    CFO, Company Secretary & Executive Director

    • Tenure: 10.6yrs
    • Compensation: US$656.43k
  • Colleen Blye (58yo)

    Non-Executive Director

    • Tenure: 5.4yrs
    • Compensation: US$56.08k
  • Keith Neilson (49yo)

    Co-Founder

    • Tenure: 20.3yrs
    • Compensation: US$878.00k

Company Information

Craneware plc's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Craneware plc
  • Ticker: CRWR.Y
  • Exchange: OTCPK
  • Founded: 1999
  • Industry: Health Care Technology
  • Sector: Healthcare
  • Market Cap: UK£684.541m
  • Listing Market Cap: UK£885.254m
  • Shares outstanding: 26.33m
  • Website: https://public.craneware.com

Number of Employees


Location

  • Craneware plc
  • 1 Tanfield
  • Edinburgh
  • EH3 5DA
  • United Kingdom

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
CRWAIM (London Stock Exchange AIM Market)YesOrdinary SharesGBGBPSep 2007
CRWR.FOTCPK (Pink Sheets LLC)YesOrdinary SharesUSUSDSep 2007
CRWR.YOTCPK (Pink Sheets LLC)SPONSORED ADRUSUSDJul 2010

Biography

Craneware plc, together with its subsidiaries, develops, licenses, and supports computer software for the healthcare industry in the United States. The company offers patient engagement solutions, such as  ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/04/24 00:25
End of Day Share Price2019/04/05 00:00
Earnings2018/12/31
Annual Earnings2018/06/30


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.